HK1182003A1 - 包含種或多種藻酸鹽的抗胃液的藥物或營養製劑 - Google Patents
包含種或多種藻酸鹽的抗胃液的藥物或營養製劑Info
- Publication number
- HK1182003A1 HK1182003A1 HK13109297.6A HK13109297A HK1182003A1 HK 1182003 A1 HK1182003 A1 HK 1182003A1 HK 13109297 A HK13109297 A HK 13109297A HK 1182003 A1 HK1182003 A1 HK 1182003A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- salts
- alginic acid
- resistant pharmaceutical
- gastric resistant
- nutraceutical formulation
- Prior art date
Links
- 229960001126 alginic acid Drugs 0.000 title 1
- 235000010443 alginic acid Nutrition 0.000 title 1
- 229920000615 alginic acid Polymers 0.000 title 1
- 239000000783 alginic acid Substances 0.000 title 1
- 150000004781 alginic acids Chemical class 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 230000002496 gastric effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000002417 nutraceutical Substances 0.000 title 1
- 235000021436 nutraceutical agent Nutrition 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2378CH2010 | 2010-08-18 | ||
PCT/EP2011/055809 WO2012022498A1 (en) | 2010-08-18 | 2011-04-13 | Gastric resistant pharmaceutical or nutraceutical formulation comprising one or more salts of alginic acid |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1182003A1 true HK1182003A1 (zh) | 2013-11-22 |
Family
ID=44168760
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK13109297.6A HK1182003A1 (zh) | 2010-08-18 | 2013-08-08 | 包含種或多種藻酸鹽的抗胃液的藥物或營養製劑 |
Country Status (13)
Country | Link |
---|---|
US (1) | US9492394B2 (zh) |
EP (1) | EP2605759B1 (zh) |
JP (1) | JP5705319B2 (zh) |
KR (1) | KR101873075B1 (zh) |
CN (1) | CN103068376B (zh) |
AU (1) | AU2011290958B2 (zh) |
BR (1) | BR112013003581B8 (zh) |
CA (1) | CA2808546C (zh) |
ES (1) | ES2716550T3 (zh) |
HK (1) | HK1182003A1 (zh) |
MX (1) | MX360389B (zh) |
RU (1) | RU2013111605A (zh) |
WO (1) | WO2012022498A1 (zh) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6161701B2 (ja) * | 2012-08-27 | 2017-07-12 | エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツングEvonik Roehm GmbH | 徐放特性及びエタノールの影響に対する耐性を有する医薬又は栄養補助組成物 |
PL2887925T3 (pl) * | 2012-08-27 | 2017-07-31 | Evonik Röhm Gmbh | Odporna żołądkowo kompozycja farmaceutyczna lub nutraceutyczna z odpornością na wpływ etanolu |
CA2888278A1 (en) * | 2012-10-15 | 2014-04-24 | Isa Odidi | Oral drug delivery formulations |
CN104688775A (zh) * | 2013-12-04 | 2015-06-10 | 博晖(大连)实业有限公司 | 一种含海星成份的组合胃药 |
EP3107529A1 (en) * | 2014-02-17 | 2016-12-28 | Evonik Röhm GmbH | Pharmaceutical or nutraceutical composition with sustained release characteristic and with resistance against the influence of ethanol |
CA2910865C (en) | 2014-07-15 | 2016-11-29 | Isa Odidi | Compositions and methods for reducing overdose |
CA2936741C (en) * | 2014-10-31 | 2018-11-06 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
BR112017013598A2 (pt) * | 2014-12-23 | 2018-03-06 | Fmc Corp | composições de revestimento de película entérico, método de revestimento, e formas revestidas |
EP3288556A4 (en) * | 2015-04-29 | 2018-09-19 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
BR112017025148A2 (pt) | 2015-06-05 | 2018-08-07 | Evonik Röhm Gmbh | composição farmacêutica ou nutracêutica com resistência contra a influência do etanol |
EP3167879A1 (en) * | 2015-11-10 | 2017-05-17 | Evonik Technochemie GmbH | Gastric retention active delivery systems |
JP6801203B2 (ja) * | 2016-03-18 | 2020-12-16 | 日油株式会社 | pH応答溶出性被覆造粒物および食品 |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
JP7111104B2 (ja) * | 2017-08-09 | 2022-08-02 | ライオン株式会社 | コーティング組成物、コーティング膜、コーティング製剤及びその製造方法 |
EP3694491A1 (en) | 2017-10-10 | 2020-08-19 | Capsugel Belgium NV | Gelling multiparticulates |
MX2022000619A (es) * | 2019-07-16 | 2022-03-11 | Astrazeneca Ab | Composiciones farmaceuticas resistentes a la descarga de dosis que comprenden venirunad. |
CN117794518A (zh) | 2021-07-29 | 2024-03-29 | 营养与生物科学美国1有限责任公司 | 控释包衣剂 |
EP4176874A1 (en) | 2021-11-09 | 2023-05-10 | Evonik Operations GmbH | Pharmaceutical or nutraceutical composition with an alcohol resistant single layer coating system |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0725663B2 (ja) | 1985-03-11 | 1995-03-22 | 大正製薬株式会社 | 腸溶性軟カプセルの製造方法 |
US5882715A (en) | 1995-06-20 | 1999-03-16 | Pharma-Vinci A/S | Method of preparing an oral preparation provided on the outer side with an enteric coating, as well as an oral preparation obtained by the method |
US5811126A (en) * | 1995-10-02 | 1998-09-22 | Euro-Celtique, S.A. | Controlled release matrix for pharmaceuticals |
DE10011447A1 (de) | 2000-03-10 | 2001-09-20 | Roehm Gmbh | Dispersion mit nichtionischem Emulgator |
US6544556B1 (en) * | 2000-09-11 | 2003-04-08 | Andrx Corporation | Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor |
US6620426B2 (en) * | 2001-06-05 | 2003-09-16 | Isp Investments Inc. | Tablet coating composition |
US20040253309A1 (en) * | 2003-01-27 | 2004-12-16 | Yamanouchi Pharmaceutical Co., Ltd. | Enteric sustained-release fine particles of tamsulosin and its salt and manufacturing method thereof |
JP2004249231A (ja) * | 2003-02-21 | 2004-09-09 | Takeda Chem Ind Ltd | 粒状物の製造方法とその装置 |
GB0320020D0 (en) * | 2003-08-27 | 2003-10-01 | Mw Encap Ltd | Improved formulation for providing an enteric coating material |
DE102004011349A1 (de) | 2004-03-05 | 2005-09-22 | Basf Ag | Wässrige Polymerdispersion auf Basis von Alkyl(meth)-acrylaten |
TW200533391A (en) * | 2004-03-25 | 2005-10-16 | Sun Pharmaceutical Ind Ltd | Gastric retention drug delivery system |
AU2005231145B8 (en) * | 2004-03-31 | 2010-11-11 | Bpsi Holdings, Inc. | Enteric coatings for orally ingestible substrates |
CA2561700A1 (en) * | 2004-04-16 | 2005-12-15 | Santarus, Inc. | Combination of proton pump inhibitor, buffering agent, and prokinetic agent |
KR100676075B1 (ko) * | 2005-02-17 | 2007-02-01 | 한국유나이티드제약 주식회사 | 경구투여용 클래리스로마이신 함유 펠렛 제제 |
WO2006102964A2 (en) * | 2005-03-29 | 2006-10-05 | Evonik Röhm Gmbh | Multiparticulate pharmaceutical form comprising pellets with a substance having a modular effect in relation to active ingredient release |
US7645802B2 (en) * | 2005-06-27 | 2010-01-12 | Biovail Laboratories International Srl. | Bupropion hydrobromide and therapeutic applications |
US9048951B2 (en) | 2005-09-02 | 2015-06-02 | Georgios Margaritis | Free space optics photodetector and transceiver |
US20070104789A1 (en) | 2005-11-04 | 2007-05-10 | Donald Spector | Gastro-resistant and ethanol-resistant controlled-release formulations comprising hydromorphone |
WO2007063553A1 (en) * | 2005-11-29 | 2007-06-07 | Ideal Cures Pvt. Ltd. | Aqueous film coating composition containing sodium alginate and preparation thereof |
MX2009010556A (es) * | 2007-03-29 | 2009-10-22 | Panacea Biotec Ltd | Formas de dosificacion modificada de tacrolimus. |
MX2010001071A (es) * | 2007-07-27 | 2010-03-09 | Depomed Inc | Formas de dosificacion retentivas gastricas pulsatiles. |
US9700520B2 (en) * | 2007-09-21 | 2017-07-11 | Evonik Roehm Gmbh | PH-dependent controlled release pharmaceutical opioid composition with resistance against the influence of ethanol |
-
2011
- 2011-04-13 KR KR1020137006647A patent/KR101873075B1/ko active IP Right Grant
- 2011-04-13 EP EP11714754.6A patent/EP2605759B1/en not_active Not-in-force
- 2011-04-13 US US13/086,079 patent/US9492394B2/en active Active
- 2011-04-13 MX MX2013001824A patent/MX360389B/es active IP Right Grant
- 2011-04-13 RU RU2013111605/15A patent/RU2013111605A/ru not_active Application Discontinuation
- 2011-04-13 CA CA2808546A patent/CA2808546C/en active Active
- 2011-04-13 JP JP2013524383A patent/JP5705319B2/ja not_active Expired - Fee Related
- 2011-04-13 WO PCT/EP2011/055809 patent/WO2012022498A1/en active Application Filing
- 2011-04-13 CN CN201180040052.6A patent/CN103068376B/zh not_active Expired - Fee Related
- 2011-04-13 AU AU2011290958A patent/AU2011290958B2/en not_active Ceased
- 2011-04-13 BR BR112013003581A patent/BR112013003581B8/pt not_active IP Right Cessation
- 2011-04-13 ES ES11714754T patent/ES2716550T3/es active Active
-
2013
- 2013-08-08 HK HK13109297.6A patent/HK1182003A1/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2012022498A1 (en) | 2012-02-23 |
MX2013001824A (es) | 2013-03-08 |
AU2011290958B2 (en) | 2014-06-19 |
KR20130099944A (ko) | 2013-09-06 |
US9492394B2 (en) | 2016-11-15 |
AU2011290958A1 (en) | 2013-04-04 |
BR112013003581B1 (pt) | 2021-07-13 |
CA2808546A1 (en) | 2012-02-23 |
CA2808546C (en) | 2018-02-20 |
BR112013003581A2 (pt) | 2016-06-07 |
JP5705319B2 (ja) | 2015-04-22 |
US20120093926A1 (en) | 2012-04-19 |
JP2013535509A (ja) | 2013-09-12 |
RU2013111605A (ru) | 2014-09-27 |
EP2605759B1 (en) | 2018-11-21 |
MX360389B (es) | 2018-10-31 |
BR112013003581B8 (pt) | 2022-07-05 |
EP2605759A1 (en) | 2013-06-26 |
KR101873075B1 (ko) | 2018-06-29 |
ES2716550T3 (es) | 2019-06-13 |
CN103068376A (zh) | 2013-04-24 |
CN103068376B (zh) | 2016-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1182003A1 (zh) | 包含種或多種藻酸鹽的抗胃液的藥物或營養製劑 | |
PL2515941T3 (pl) | Preparat farmaceutyczny zawierający bewacyzumab | |
ZA201308086B (en) | Derivatives of 1-anino-2-cyclopropylboronic acid | |
EP3378506C0 (en) | DRUG RELEASING COATINGS FOR MEDICAL DEVICES | |
ZA201208336B (en) | Controlled release pharmaceutical compositions of tapentadol | |
ZA201206254B (en) | Novel salts for the manufacture of pharmaceutical compositions | |
EP2560484A4 (en) | PHARMACEUTICAL COMPOSITION FROM NANOPARTICLES | |
HK1191572A1 (zh) | 適用於藥物或營養製品劑型的包衣組合物 | |
EP2616053A4 (en) | PHARMACEUTICAL COMPOSITIONS FROM CURCUMIN | |
IL228397A0 (en) | A coating preparation suitable for dosage forms of pharmaceuticals or nutritional supplements | |
EP2616059A4 (en) | PHARMACEUTICAL AND NUTRACEUTICAL COMPOSITIONS OF ABSCISIC ACID | |
GB2486567B (en) | Pharmaceutical formulation | |
HK1169379A1 (zh) | -戊基苯乙酸的鹽及其藥物用途 | |
EP2599484A4 (en) | INJECTABLE PHARMACEUTICAL PREPARATION OF MELPHALANE | |
EP2637655A4 (en) | PHARMACEUTICAL COMPOSITION OF TAXOIDES | |
IL221087A (en) | Pharmacy or nutritional composition | |
IL222625A0 (en) | A solid pharmaceutical composition for neutralizing stomach acid | |
EP2523654A4 (en) | IMMEDIATE RELEASE COMPOSITIONS OF MEDICAMENTS LABILES ACIDES | |
PL2702060T3 (pl) | Kwasowe addycyjne sole risperidonu i ich kompozycje farmaceutyczne | |
PL2632443T3 (pl) | Wytwarzanie orodyspergowalnych lamelek | |
EP2760435A4 (en) | AUTHENTICABLE COATINGS FOR PHARMACEUTICAL TABLETS AND INGREDIENTS | |
PT2654770T (pt) | Composições farmacêuticas de tenecteplase | |
HK1188959A1 (zh) | 磷霉素藥物組合物 | |
HUP1100272A2 (en) | Pharmaceutical use of silicic acid | |
GB201003342D0 (en) | Manufacture of insoluble drugs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20230415 |